Is Apellis Pharmaceuticals Inc (NASDAQ: APLS) a Risk-Worthy Bet for Bold Investors?
In the last trading session, 2.55 million Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares changed hands as the company’s beta touched 0.67. With the company’s per share